Skip to content
Shuttingdown

VOLITIONRX LTD

In Vitro & In Vivo Diagnostic Substances · HENDERSON · NV

Distress signal

Moderate confidence (50%)

Updated Oct 11, 2026, 12:05 AM

What is happening

Derived by rule set status-rules-2026.09.7

An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

Latest material event: VOLITIONRX LTD received a delisting notice from its exchange (Apr 23, 2026)

Timeline

Every material event, newest first. History is never overwritten.

  1. VOLITIONRX LTD received a delisting notice from its exchange

    Apr 23, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed under Item 3.01 of the Current Report on Form 8-K filed with the Securities and Exchange Commission on February 9, 2026, VolitionRx Limited (the Company ) received a notice (the Notice ) from the NYSE American LLC (the NYSE American ) indicating that the Company was not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the Company Guide ) requiring a company to have stockholders…”
  2. VOLITIONRX LTD received a delisting notice from its exchange

    Feb 6, 2026

    Delisting notice received

    • SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On February 6, 2026, VolitionRx Limited (the Company ) received a notice (the Notice ) from the NYSE American LLC (the NYSE American ) stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the Company Guide ) requiring a company to have stockholders equity of at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most r…”

Company information

Founded
—
Employees (estimate)
—
Industry
In Vitro & In Vivo Diagnostic Substances
Subindustry
—
Listing
SEC lists the ticker VNRX on NYSE.
SEC CIK
0000093314
Website
—
LinkedIn
—
Headquarters
HENDERSON, NV
Also known as
STANDARD CAPITAL CORP, VOLITIONRX LTD
Legal entities
VOLITIONRX LTD

Sources

Every material source used to build this profile.

  • SEC Company Submissions (TIER 1 · UNVERIFIED)

    VOLITIONRX LTD — In Vitro & In Vivo Diagnostic Substances (SIC 2835) — HENDERSON, NV
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed under Item 3.01 of the Current Report on Form 8-K filed with the Securities and Exchange Commission on February 9, 2026, VolitionRx Limited (the Company ) received a notice (the Notice ) from the NYSE American LLC (the NYSE American ) indicating that the Company was not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the Company Guide ) requiring a company to have stockholders…
    View source record
  • SEC EDGAR (TIER 1 · UNVERIFIED)

    Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing On February 6, 2026, VolitionRx Limited (the Company ) received a notice (the Notice ) from the NYSE American LLC (the NYSE American ) stating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the Company Guide ) requiring a company to have stockholders equity of at least $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most r…
    View source record

Status history

Every derived status, with the rule that produced it.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:30 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:13 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:35 PM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 13, 2026, 12:04 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.

  • UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:04 AM

    An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.